Antibodies for Nuclear Medicine Therapy

作者: David M. Goldenberg , Robert M. Sharkey

DOI: 10.1007/174_2012_670

关键词:

摘要: Immunoglobulin G (IgG) is a unique molecule with the capability of exquisite binding specificity. Its ability to bind antigens an integral component our immune system for clearing foreign cells from body. In some instances, mere IgG cell surface can elicit signals that trigger death. Although unconjugated antibodies have had increasing role in oncology and autoimmune disorders over past 10-15 years, 50+ has primarily been used target other compounds tumors goal illuminate surrounding normal tissues through imaging technologies, or therapy using variety cytotoxic agents, such as radionuclides, drugs, toxins, biological agents. Radioconjugates are perspective they allow both better detection also deliver dose radiation. The activity be manifested across many layers strong beta-emitters, narrower field alpha-emitters. radiolabeled approved use mostly follicular non-Hodgkin lymphoma, their effectiveness solid more challenging. This chapter provides brief overview how radioimmunoconjugates progressed potential future.

参考文章(165)
Kathleen R. Lamborn, David L. Kukis, Carol M. Richman, Linda A. Kroger, Sally J. DeNardo, Gerald L. Denardo, Laird A. Miers, Sui Shen, Edith A. Perez, Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol. Anticancer Research. ,vol. 18, pp. 4011- 4018 ,(1998)
F. Buchegger, J.-P. Mach, S. Folli, B. Delaloye, A. Bischof-Delaloye, A. Pèlegrin, Higher Efficiency of 131I-Labeled Anti-Carcinoembryonic Antigen—Monoclonal Antibody F(ab′)2 as Compared to Intact Antibodies in Radioimmunotherapy of Established Human Colon Carcinoma Grafted in Nude Mice Systemic Radiotherapy with Monoclonal Antibodies. ,vol. 141, pp. 19- 35 ,(1996) , 10.1007/978-3-642-79952-5_3
Alessio Pio Perrotti, Pasquale Niscola, Sergio Boemi, Laura Scaramucci, Teresa Dentamaro, Massimiliano Palombi, Micaela Ales, Luca Cupelli, Andrea Tendas, Daniela Piccioni, Marco Giovannini, Virginia Naso, Maurizio Martelli, Paolo de Fabritiis, Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy. Tumori. ,vol. 95, pp. 129- 130 ,(2009) , 10.1177/030089160909500125
Burt Nabors, Andres Forero, Michael Yester, Ruby Meredith, Sui Shen, Albert Lobuglio, Jatin J. Shah, Case report of a patient with primary central nervous system lymphoma treated with radioimmunotherapy. Clinical Lymphoma, Myeloma & Leukemia. ,vol. 7, pp. 236- 238 ,(2006)
Daming Shan, Jeffrey A. Ledbetter, Oliver W. Press, Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies Blood. ,vol. 91, pp. 1644- 1652 ,(1998) , 10.1182/BLOOD.V91.5.1644
D. J. Buchsbaum, P. L. Roberson, Experimental Radioimmunotherapy: Biological Effectiveness and Comparison with External Beam Radiation Systemic Radiotherapy with Monoclonal Antibodies. ,vol. 141, pp. 9- 18 ,(1996) , 10.1007/978-3-642-79952-5_2
J. A. Carrasquillo, I. Hellström, K. E. Hellström, K. A. Krohn, J. P. Brown, S. M. Larson, R. W. McGuffin, P. Beaumier, Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer treatment reports. ,vol. 68, pp. 317- 328 ,(1984)
Sally J. DeNardo, Gerald L. DeNardo, Lois F. O'Grady, Daniel J. Macey, Stanley L. Mills, Alan L. Epstein, Jo-Sen Peng, John P. McGahan, Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodies. International Journal of Biological Markers. ,vol. 2, pp. 49- 53 ,(1987) , 10.1177/172460088700200107
D.S. Ettinger, M.K. Parker, J.L. Klein, S.E. Order, P.K. Leichner, Wharam, Phase I-II study of isotopic immunoglobulin therapy for primary liver cancer. Cancer treatment reports. ,vol. 66, pp. 289- 297 ,(1982)
Frits Aarts, Robert P. Bleichrodt, Wim J.G. Oyen, Otto C. Boerman, Intracavitary radioimmunotherapy to treat solid tumors. Cancer Biotherapy and Radiopharmaceuticals. ,vol. 23, pp. 92- 107 ,(2008) , 10.1089/CBR.2007.0412